Pfizer and OPKO’s Once-Weekly NGENLATM (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency :: OPKO Health, Inc. (OPK)

Jennifer E. Engen

Pfizer and OPKO’s Once-Weekly NGENLATM (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency     NEW YORK and MIAMI, February 15, 2022 – Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) […]